ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Amgen


Include trials that are no longer recruiting patients.

58 studies were found. Here are studies 1 to 50.
1.RecruitingABX-EGF Monotherapy in Subjects with Metastatic Colorectal Cancer
Conditions: Colorectal Cancer; Metastases
2.RecruitingAMG 162 in Biphosphonate Naive Metastatic Breast Cancer
Conditions: Breast Cancer; Metastases
3.RecruitingAMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
Condition: Prostate Cancer
4.RecruitingAMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Condition: Breast Cancer
5.No longer recruitingAnemia in Patients with a Non-Myeloid Malignancy
Conditions: Anemia; Neoplasms
6.RecruitingChemotherapy Administered Every 2 Weeks with or without Pegfilgrastim (Neulasta) in Subjects with Advanced Colon Cancer
Conditions: Colon Cancer; Colorectal Cancer; Rectal Cancer
7.CompletedChemotherapy Related Anemia
Conditions: Lymphoma; Leukemia, Lymphocytic, Chronic; Multiple Myeloma; Breast Neoplasms; Lung Neoplasms
8.CompletedChemotherapy Related Anemia in Patients with Non-Myeloid Malignancies
Conditions: Lymphomas; Breast Neoplasms; Lung Neoplasms; Multiple Myeloma; Leukemia, Lymphocytic, Chronic
9.RecruitingCinacalcet HCl in Chronic Kidney Disease Subjects with Secondary Hyperparathyroidism Not Receiving Dialysis
Conditions: Kidney Diseases; Chronic Disease
10.No longer recruitingCombination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
Conditions: stage II prostate cancer; Pain; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
11.No longer recruitingCombination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
Conditions: stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; transitional cell carcinoma of the bladder; ...
12.No longer recruitingCombination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
Condition: Lymphoma
13.CompletedComparison of Liposomal Doxorubicin Used Alone or in Combination with Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients with AIDS
Conditions: Sarcoma, Kaposi; HIV Infections
14.RecruitingDarbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects with Anemia of Cancer
Condition: Anemia
15.No longer recruitingDocetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
16.CompletedThe Effects of r-metHuIFN-gamma on the Lungs of Patients with AIDS
Condition: HIV Infections
17.RecruitingEfficacy, Safety and Tolerability of AMG 162 in the Treatment of Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
18.RecruitingEtanercept (Enbrel®) in Psoriasis - Pediatrics
Condition: Psoriasis
19.No longer recruitingEvaluation of the Efficacy of Combination Treatment with Anakinra and Pegsunercept in Improving Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
20.CompletedEvaluation of the Therapeutic Benefit of r-metHuIFN- gamma in AIDS Patients With Disseminated Mycobacterium Avium-Intracellulare (MAI) Infection: A Multi-Centered Pilot Study
Conditions: Mycobacterium avium-intracellulare Infection; HIV Infections
21.No longer recruitingHeart Failure and Anemia
Conditions: Heart Failure; Anemia
22.No longer recruitingJuvenile Rheumatoid Arthritis
Condition: Juvenile Chronic Arthritis
23.No longer recruitingMonoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (low-grade)
Condition: Non-Hodgkin's Lymphoma
24.RecruitingNavelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
Condition: Breast Cancer
25.CompletedAn Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)
Condition: HIV Infections
26.No longer recruitingPegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
Condition: Neutropenia
27.RecruitingPegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy
Conditions: Sarcoma; Neutropenia
28.RecruitingPegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer; Carcinoma, Non-Small-Cell Lung
29.No longer recruitingPegfilgrastim PBPC Mobilization Study
Conditions: Lymphoma; Hodgkin Disease; Lymphoma, Non-Hodgkin; Hematology; Oncology
30.RecruitingPharmacokinetic study of palifermin in subjects receiving radiation therapy and chemotherapy followed by blood stem cell support
Conditions: Leukemia; Lymphoma; Myeloma
31.No longer recruitingPhase 2 Study assessing AMG 162 in the treatment of women with low bone density
Conditions: Osteopenia; Osteoporosis
32.CompletedPhase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease
Conditions: HIV Infections; Hodgkin's Disease
33.RecruitingPreference of Rheumatoid Arthritis (RA) Patients of Enbrel® (etanercept) Auto-Injector versus Enbrel® Pre-Filled Syringes
Condition: Rheumatoid Arthritis
34.CompletedA Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
Conditions: HIV Infections; Cytopenias
35.CompletedRecombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy
Condition: Stomatitis
36.RecruitingRegistry of Etanercept (Enbrel®) In Children with Juvenile Rheumatoid Arthritis
Condition: Arthritis, Juvenile Rheumatoid
37.TerminatedA Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate
Condition: Arthritis, Rheumatoid
38.RecruitingSafety and Efficacy Study of Etanercept (Enbrel®) In Children with Systemic Onset Juvenile Rheumatoid Arthritis
Condition: Arthritis, Juvenile Rheumatoid
39.RecruitingSafety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients
Conditions: Scleroderma; Systemic Sclerosis
40.RecruitingStudy Evaluating AMG 706 in Subjects with Advanced Solid Tumors
Condition: Tumors
41.RecruitingStudy of AMG 706 in Subjects with Advanced Gastrointestinal Stromal Tumors (GISTs)
Condition: Gastrointestinal Cancer
42.No longer recruitingA Study of an Investigational Medication for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients
Conditions: Secondary Hyperparathyroidism; Chronic Renal Insufficiency
43.RecruitingA Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer
Conditions: Hyperparathyroidism; Parathyroid Neoplasms
44.CompletedA Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
Conditions: Secondary Hyperparathyroidism; End Stage Renal Disease
45.No longer recruitingA Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis
Conditions: Secondary Hyperparathyroidism; End Stage Renal Disease
46.RecruitingStudy of Darbepoetin Alfa for the Treatment of Anemia of Cancer
Conditions: Anemia; Cancer
47.RecruitingA Study of Darbepoetin Alfa in Anemic Subjects with Low Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
48.CompletedA Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients with AIDS or AIDS-Related Complex
Conditions: HIV Infections; Cytopenias
49.RecruitingStudy to Assess Darbepoetin Alfa in Subjects with Chronic Kidney Disease
Conditions: Kidney Disease; Chronic Disease
50.RecruitingStudy to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis
Condition: Postmenopausal Osteoporosis

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act